{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:22:53Z","timestamp":1786123373454,"version":"build-2736575974"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,1]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>\n                      End-stage renal disease (ESRD) has been shown to be associated with abnormal neural function. Clinically used inhaled anesthetic agents typically exert their effect through multiple target receptors in the central nervous system. Pathological changes in the brain may alter sensitivity to inhaled anesthetic agents. This study aimed to determine the minimum alveolar concentration-awake (MAC\n                      <jats:sub>awake<\/jats:sub>\n                      ) of sevoflurane in patients with ESRD compared to patients with normal renal function.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>Patients underwent inhalational induction of anesthesia and received sevoflurane at a preselected concentration according to a modified Dixon \u201cup-and-down\u201d method starting at 1.0% with a step size of 0.2%. The concentration of sevoflurane used for each consecutive patient was increased or decreased based on a positive or negative response to verbal command in the previous patient. Serum neuron-specific enolase, a biomarker of impaired neurons, was also measured.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      Forty-one patients were enrolled: 20 with ESRD and 21 as controls. The MAC\n                      <jats:sub>awake<\/jats:sub>\n                      of sevoflurane in patients with ESRD was significantly lower than that observed in the control group (0.56% [standard deviation {SD} = 0.10%] vs 0.67% [SD = 0.08%];\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .031). Patients with ESRD exhibited higher serum neuron-specific enolase levels compared to the control group (16.4 ng\/mL [SD = 5.0] vs 8.7 ng\/mL [SD = 2.9];\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>\n                      MAC\n                      <jats:sub>awake<\/jats:sub>\n                      of sevoflurane is somewhat lower in patients with ESRD compared to those with normal renal function. Impaired cerebral function may partly contribute to the reduction in anesthetic requirement.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1213\/ane.0000000000003676","type":"journal-article","created":{"date-parts":[[2018,7,24]],"date-time":"2018-07-24T22:07:06Z","timestamp":1532470026000},"page":"77-82","source":"Crossref","is-referenced-by-count":11,"title":["Minimum Alveolar Concentration-Awake of Sevoflurane Is Decreased in Patients With End-Stage Renal Disease"],"prefix":"10.1213","volume":"128","author":[{"given":"Yun","family":"Wu","sequence":"first","affiliation":[{"name":"Department of Anesthesiology, Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyun","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Anhui Provincial Hospital, Hefei, Anhui, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianwen","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230721","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1111\/j.1532-5415.2004.52508.x","article-title":"Cognitive impairment in chronic kidney disease.","volume":"52","author":"Kurella","year":"2004","journal-title":"J Am Geriatr Soc"},{"key":"R2-20230721","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.krcp.2014.07.003","article-title":"Chronic renal failure induces cell death in rat hippocampal CA1 via upregulation of \u03b1CaMKII\/NR2A synaptic complex and phosphorylated GluR1-containing AMPA receptor cascades.","volume":"33","author":"Kim","year":"2014","journal-title":"Kidney Res Clin Pract"},{"key":"R3-20230721","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1017\/S1355617711001445","article-title":"Risk factors for selective cognitive decline in dialyzed patients with end-stage renal disease: evidence from verbal fluency analysis.","volume":"18","author":"Harciarek","year":"2012","journal-title":"J Int Neuropsychol Soc"},{"key":"R4-20230721","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1038\/sj.jcbfm.9600478","article-title":"Cerebrovascular effects of hemodialysis in chronic kidney disease.","volume":"27","author":"Prohovnik","year":"2007","journal-title":"J Cereb Blood Flow Metab"},{"key":"R5-20230721","first-page":"68","article-title":"A preliminary report of brain edema in patients with uremia at first hemodialysis: evaluation by diffusion-weighted MR imaging.","volume":"28","author":"Chen","year":"2007","journal-title":"AJNR Am J Neuroradiol"},{"key":"R6-20230721","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1007\/s000180050371","article-title":"General anaesthetic actions on ligand-gated ion channels.","volume":"55","author":"Krasowski","year":"1999","journal-title":"Cell Mol Life Sci"},{"key":"R7-20230721","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/367607a0","article-title":"Molecular and cellular mechanisms of general anaesthesia.","volume":"367","author":"Franks","year":"1994","journal-title":"Nature"},{"key":"R8-20230721","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/bja\/71.1.134","article-title":"Excitatory and inhibitory synaptic mechanisms in anaesthesia.","volume":"71","author":"Pocock","year":"1993","journal-title":"Br J Anaesth"},{"key":"R9-20230721","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/TP.0000000000000874","article-title":"Sevoflurane versus desflurane on the incidence of postreperfusion syndrome during living donor liver transplantation: a randomized controlled trial.","volume":"100","author":"Lee","year":"2016","journal-title":"Transplantation"},{"key":"R10-20230721","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1111\/anae.13208","article-title":"The discriminatory value of cardiorespiratory interactions in distinguishing awake from anaesthetised states: a randomised observational study.","volume":"70","author":"Kenwright","year":"2015","journal-title":"Anaesthesia"},{"key":"R11-20230721","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1097\/00000539-200105000-00020","article-title":"Modulation of NMDA receptor function by ketamine and magnesium. Part II: interactions with volatile anesthetics.","volume":"92","author":"Hollmann","year":"2001","journal-title":"Anesth Analg"},{"key":"R12-20230721","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1097\/00000542-200309000-00024","article-title":"The actions of sevoflurane and desflurane on the gamma-aminobutyric acid receptor type A: effects of TM2 mutations in the alpha and beta subunits.","volume":"99","author":"Nishikawa","year":"2003","journal-title":"Anesthesiology"},{"key":"R13-20230721","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s00540-014-1822-x","article-title":"Sevoflurane in combination with propofol, not thiopental, induces a more robust neuroapoptosis than sevoflurane alone in the neonatal mouse brain.","volume":"28","author":"Tagawa","year":"2014","journal-title":"J Anesth"},{"key":"R14-20230721","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1093\/bja\/aeu400","article-title":"Effects of different remifentanil target concentrations on MAC BAR of sevoflurane in gynaecological patients with CO2 pneumoperitoneum stimulus.","volume":"114","author":"Zou","year":"2015","journal-title":"Br J Anaesth"},{"key":"R15-20230721","doi-asserted-by":"crossref","first-page":"e6235","DOI":"10.1097\/MD.0000000000006235","article-title":"The optimal exhaled concentration of sevoflurane for intubation without neuromuscular blockade using clinical bolus doses of remifentanil: a randomized controlled trial.","volume":"96","author":"Goo","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"R16-20230721","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.neubiorev.2016.05.009","article-title":"Blood biomarkers for brain injury: what are we measuring?","volume":"68","author":"Kawata","year":"2016","journal-title":"Neurosci Biobehav Rev"},{"key":"R17-20230721","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1213\/ANE.0000000000001791","article-title":"The effect of chronic opioid use on end-tidal concentration of sevoflurane necessary to maintain a bispectral index below 50: a prospective, single-blind study.","volume":"125","author":"Oh","year":"2017","journal-title":"Anesth Analg"},{"key":"R19-20230721","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1056\/NEJMra071313","article-title":"Uremia.","volume":"357","author":"Meyer","year":"2007","journal-title":"N Engl J Med"},{"key":"R20-20230721","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/bja\/79.4.465","article-title":"Does nitrous oxide antagonize sevoflurane-induced hypnosis?","volume":"79","author":"Katoh","year":"1997","journal-title":"Br J Anaesth"},{"key":"R21-20230721","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clineuro.2004.07.012","article-title":"Neurological complications in renal failure: a review.","volume":"107","author":"Brouns","year":"2004","journal-title":"Clin Neurol Neurosurg"},{"key":"R22-20230721","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1046\/j.1523-1755.2001.59780077.x","article-title":"Endogenous guanidino compounds as uremic neurotoxins.","volume":"78","author":"De Deyn","year":"2001","journal-title":"Kidney Int Suppl"},{"key":"R23-20230721","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1093\/ndt\/gfq729","article-title":"Cerebral metabolic alterations and cognitive dysfunction in chronic kidney disease.","volume":"26","author":"Tryc","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"R24-20230721","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1210\/jcem-51-1-130","article-title":"The relationship between the abnormalities in electroencephalogram and blood levels of parathyroid hormone in dialysis patients.","volume":"51","author":"Goldstein","year":"1980","journal-title":"J Clin Endocrinol Metab"},{"key":"R25-20230721","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1172\/JCI107984","article-title":"Changes in the electroencephalogram in acute uremia: effects of parathyroid hormone and brain electrolytes.","volume":"55","author":"Guisado","year":"1975","journal-title":"J Clin Invest"},{"key":"R26-20230721","doi-asserted-by":"crossref","first-page":"680","DOI":"10.2174\/1381612822666151204000458","article-title":"Biomarkers in silent traumatic brain injury.","volume":"22","author":"Antonopoulos","year":"2016","journal-title":"Curr Pharm Des"},{"key":"R27-20230721","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1681\/ASN.2010010116","article-title":"Inhibition of prolyl hydroxylases increases erythropoietin production in ESRD.","volume":"21","author":"Bernhardt","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"R28-20230721","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1093\/bja\/52.9.851","article-title":"Solubility and distribution of halothane in human blood.","volume":"52","author":"Pang","year":"1980","journal-title":"Br J Anaesth"},{"key":"R29-20230721","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0041-008X(90)90287-5","article-title":"Mechanism of transport and distribution of organic solvents in blood.","volume":"104","author":"Lam","year":"1990","journal-title":"Toxicol Appl Pharmacol"},{"key":"R30-20230721","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1213\/00000539-198410000-00007","article-title":"Hematocrit and the solubility of volatile anesthetics in blood.","volume":"63","author":"Lerman","year":"1984","journal-title":"Anesth Analg"},{"key":"R31-20230721","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1097\/00000539-200110000-00029","article-title":"Age, minimum alveolar anesthetic concentration, and minimum alveolar anesthetic concentration-awake.","volume":"93","author":"Eger","year":"2001","journal-title":"Anesth Analg"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00000539-201901000-00015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:32:29Z","timestamp":1786113149000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000539-201901000-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0000000000003676","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]}}}